ArticleSocial psychiatry and psychiatric epidemiology2026
Social position and antidepressant dose trajectories: a latent class analysis of a french cohort linked to the reimbursement register.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeAntidepressant (AD) doses may vary depending on symptom severity over time. Individuals in lower social positions experience more severe and recurrent depressive episodes, yet it remains unclear whether and how their AD dosage reflects this higher burden. This study aimed to identify AD dose trajectories in a population-based sample and examine their associations with social position indicators.
methodsWe used data from the French CONSTANCES cohort linked to the national drug reimbursement register. We included incident AD users who initiated a selective serotonin reuptake inhibitor or a selective norepinephrine reuptake inhibitor during their cohort inclusion year. We adopted a Latent Class Mixed Modeling framework to identify AD daily dose trajectories, adjusting for severity proxies. Multinomial regression models assessed the association between trajectory membership and baseline social position indicators.
resultsOverall, 4520 participants (63% women) were included. Four latent AD trajectories were identified: a "Constant" class including most participants (94%) characterized by stable dosing around 20 mg fluoxetine-equivalents; and three classes smaller classes showing varying patterns: a "High-decreasing" class (3.5%), a "High-sharp-decrease" class (1.32%), and "Low-slight-increase" (1.16%). In terms of social position, participants living in the most deprived areas were more likely to follow the 'High-decreasing' class than the 'Constant' one, while participants living alone were more likely to belong to the "High-sharp-decrease" class compared to the "Constant".
conclusionsAD dose trajectories showed little heterogeneity with most users following a stable dosing pattern and only small groups displaying fluctuating patterns. Social position influence may be more prominent in determining AD initiation than in shaping dose patterns over time.
Indexed as
Identifiers
42223654What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.